NCAPH enhances PD-L1 expression in ccRCC cells by inhibiting β-catenin degradation, thereby promoting aerobic glycolysis and immune tolerance (Fig. 2A) [78]. This evidence concerns the gene NCAPH and nonpapillary renal cell carcinoma.